v3.26.1
Condensed Interim Consolidated Statements of Stockholders’ (Deficiency) Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance beginning at Oct. 31, 2024 $ 2,541,515 $ 141,723,305 $ (138,814,271) $ 92,248 $ 5,542,797
Balance beginning (in Shares) at Oct. 31, 2024 47,365,652        
Exercise of warrants, net of issuance costs (Note 11) $ 2,450 79,306 81,756
Exercise of warrants, net of issuance costs (Note 11) (in Shares) 245,000        
- Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12) 27,769 27,769
Net loss (577,850) (577,850)
Balance ending at Jul. 31, 2025 $ 2,543,965 141,830,380 (139,392,121) 92,248 5,074,472
Balance ending (in Shares) at Jul. 31, 2025 47,610,652        
Balance beginning at Apr. 30, 2025 $ 2,541,730 141,750,397 (138,986,924) 92,248 5,397,451
Balance beginning (in Shares) at Apr. 30, 2025 47,387,152        
Exercise of warrants, net of issuance costs (Note 11) $ 2,235 73,543 75,778
Exercise of warrants, net of issuance costs (Note 11) (in Shares) 223,500        
- Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12) 6,440 6,440
Net loss (405,197) (405,197)
Balance ending at Jul. 31, 2025 $ 2,543,965 141,830,380 (139,392,121) 92,248 5,074,472
Balance ending (in Shares) at Jul. 31, 2025 47,610,652        
Balance beginning at Oct. 31, 2025 $ 2,560,788 142,358,630 (151,917,277) 92,248 $ (6,905,611)
Balance beginning (in Shares) at Oct. 31, 2025 49,292,882       49,292,882
Exercise of warrants, net of issuance costs (Note 11) $ 450 3,429 $ 3,879
Exercise of warrants, net of issuance costs (Note 11) (in Shares) 45,000        
Reclassification to additional paid-in capital upon exercise of warrants at price of $CDN 0.13 4,178 4,178
- Stock-based compensation for options issued to directors, officers, employees, and advisors (Note 12) 4,293 4,293
Net loss (1,361,890) (1,361,890)
Balance ending at Jul. 31, 2026 $ 2,561,238 142,370,530 (153,279,167) 92,248 $ (8,255,151)
Balance ending (in Shares) at Jul. 31, 2026 49,337,882       49,337,882
Balance beginning at Apr. 30, 2026 $ 2,560,788 142,362,923 (153,153,837) 92,248 $ (8,137,878)
Balance beginning (in Shares) at Apr. 30, 2026 49,292,882        
Exercise of warrants, net of issuance costs (Note 11) $ 450 3,429 3,879
Exercise of warrants, net of issuance costs (Note 11) (in Shares) 45,000        
Reclassification to additional paid-in capital upon exercise of warrants at price of $CDN 0.13 4,178 4,178
Net loss (125,330) (125,330)
Balance ending at Jul. 31, 2026 $ 2,561,238 $ 142,370,530 $ (153,279,167) $ 92,248 $ (8,255,151)
Balance ending (in Shares) at Jul. 31, 2026 49,337,882       49,337,882